Get started
SIMCERE PHARMAC. GRP LTDSIMCERE PHARMAC. GRP LTDSIMCERE PHARMAC. GRP LTD

SIMCERE PHARMAC. GRP LTD

No trades
See on Supercharts
Overview
Financials News Discussions Technicals Forecast Seasonals

S2P chart


Full chart

S2P upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪2.44 B‬ EUR
Dividend yield (indicated)
2.08%
Price to earnings Ratio (TTM)
25.570
Basic EPS (TTM)
0.040 EUR
Net income (FY)
‪98.81 M‬ EUR
Revenue (FY)
‪894.24 M‬ EUR
Shares float
‪572.91 M‬
Beta (1Y)
0.59

Employees


Employees (FY)
‪6.58 K‬
Change (1Y)
−443 −6.30%
Revenue / Employee (1Y)
‪135.82 K‬ EUR
Net income / Employee (1Y)
‪15.01 K‬ EUR

About SIMCERE PHARMACEUTICAL GRP LTD


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Jin Sheng Ren
Website
simcere.com
Headquarters
Nanjing
Founded
1995
ISIN
HK0000658531
FIGI
BBG00Y04NC95
Simcere Pharmaceutical Group Ltd. engages in the research, development, manufacturing, and sale of pharmaceutical products. It operates through the Sale of Pharmaceutical Products and Promotion Service Income segments. The Promotion Service Income segment includes the rendering promotion service of pharmaceutical products that are not manufactured by the firm. The company was founded by Jin Sheng Ren in 1995 and is headquartered in Nanjing, China.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

S2P news



Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as S2P.

Frequently Asked Questions


The current price of S2P is 0.970 EUR — it has increased by 1.04% in the past 24 hours. Watch SIMCERE PHARMAC. GRP LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange SIMCERE PHARMAC. GRP LTD stocks are traded under the ticker S2P.
S2P stock has risen by 9.60% compared to the previous week, the month change is a 1.04% rise, over the last year SIMCERE PHARMAC. GRP LTD has showed a 56.45% increase.
We've gathered analysts' opinions on SIMCERE PHARMAC. GRP LTD future price: according to them, S2P price has a max estimate of 1.33 EUR and a min estimate of 1.05 EUR. Watch S2P chart and read a more detailed SIMCERE PHARMAC. GRP LTD stock forecast: see what analysts think of SIMCERE PHARMAC. GRP LTD and suggest that you do with its stocks.
S2P reached its all-time high on Jan 13, 2023 with the price of 1.560 EUR, and its all-time low was 0.575 EUR and was reached on Mar 7, 2024. View more price dynamics on S2P chart.
See other stocks reaching their highest and lowest prices.
S2P stock is 1.03% volatile and has beta coefficient of 0.59. Track SIMCERE PHARMAC. GRP LTD stock price on the chart and check out the list of the most volatile stocks — is SIMCERE PHARMAC. GRP LTD there?
Today SIMCERE PHARMAC. GRP LTD has the market capitalization of ‪2.44 B‬, it has increased by 4.59% over the last week.
Yes, you can track SIMCERE PHARMAC. GRP LTD financials in yearly and quarterly reports right on TradingView.
SIMCERE PHARMAC. GRP LTD is going to release the next earnings report on Aug 21, 2025. Keep track of upcoming events with our Earnings Calendar.
S2P net income for the last half-year is ‪37.29 M‬ EUR, while the previous report showed ‪59.14 M‬ EUR of net income which accounts for −36.94% change. Track more SIMCERE PHARMAC. GRP LTD financial stats to get the full picture.
Yes, S2P dividends are paid annually. The last dividend per share was 0.02 EUR. As of today, Dividend Yield (TTM)% is 2.13%. Tracking SIMCERE PHARMAC. GRP LTD dividends might help you take more informed decisions.
SIMCERE PHARMAC. GRP LTD dividend yield was 2.42% in 2024, and payout ratio reached 54.15%. The year before the numbers were 2.61% and 58.03% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Apr 3, 2025, the company has ‪6.58 K‬ employees. See our rating of the largest employees — is SIMCERE PHARMAC. GRP LTD on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SIMCERE PHARMAC. GRP LTD EBITDA is ‪164.66 M‬ EUR, and current EBITDA margin is 18.43%. See more stats in SIMCERE PHARMAC. GRP LTD financial statements.
Like other stocks, S2P shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SIMCERE PHARMAC. GRP LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SIMCERE PHARMAC. GRP LTD technincal analysis shows the strong buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SIMCERE PHARMAC. GRP LTD stock shows the buy signal. See more of SIMCERE PHARMAC. GRP LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.